跳至主要内容
临床试验/NCT07232342
NCT07232342招募中不适用

Capillary Leak Index Versus Conventional Biomarkers in Predicting Sepsis-Related Outcomes

Benha University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年12月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
all-cause mortality

研究概览

简要总结

This study aims to evaluate the prognostic significance of CLI in predicting 28-day mortality and other outcomes in critically ill patients who develop post-operative abdominal sepsis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age ≥ 18 years.
  • •Postoperative secondary peritonitis requiring ICU admission, with clinical evidence of:
  • •Diffuse or localized abdominal pain/tenderness. Peritoneal signs (e.g., guarding, rigidity, rebound tenderness). Imaging or intraoperative confirmation of purulent/exudative intra-abdominal fluid.
  • •Systemic inflammation (e.g., fever, leukocytosis, or vasopressor requirement). Sepsis diagnosis per Sepsis-3 criteria: Suspected/confirmed infection with acute increase in SOFA score ≥2 points (6).
  • •Anticipated ICU stay ≥48 hours postoperatively.

排除标准

  • •Pregnancy
  • •Advanced liver disease (Child-Pugh class B or C) that might independently affect albumin levels
  • •Advanced kidney disease (CKD stage 4 or 5) or patients on chronic dialysis
  • •Expected mortality within 48 hours of ICU admission
  • •Patients with primary peritonitis or tertiary peritonitis
  • •Immunocompromised patients (e.g., on chronic immunosuppressive therapy, solid organ transplant recipients, patients with HIV and CD4 count <200/mm³)
  • •Patients with pre-existing systemic inflammatory diseases that might affect baseline CRP levels
  • •Patients participating in interventional trials that might affect outcomes

结局指标

主要结局

all-cause mortality

时间窗: From 1-10-2025 to 1-10-2026

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Samar Rafik Mohamed Amin

Dr

Benha University

研究点 (1)

Loading locations...

相似试验